HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial.

AbstractBACKGROUND:
To evaluate the effect of brimonidine tartrate 0.15% ophthalmic solution on pupil size under scotopic condition and upper eyelid position.
METHODS:
This study comprised 72 eyes of 36 healthy subjects. A single drop of brimonidine tartrate 0.15% ophthalmic solution was instilled in the right eye and artificial tear was instilled in the left eye. Pupil size was measured using an infra-red pupillometer under scotopic condition before and at 30 min, 2, 4, 6, 8 and 10 h after instillation. Measurement of margin reflex distance 1 (MRD1) was performed using a millimetre ruler before and after at 10 min after instillation.
RESULTS:
The mean age of the subjects was 32.19 ± 11.43 years (range 10-52 years), 17 were female and 19 were male. Before brimonidine instillation, the mean pupil size was 6.09 ± 1.03 mm in the brimonidine eyes and 6.06 ± 1.04 mm in the control eyes. There was a significant decrease in mean pupil size at 30 min (4.45 ± 1.04), 2 h (4.49 ± 1.06), 4 h (4.59 ± 1.06), 6 h (4.89 ± 1.06) and 8 h (5.38 ± 1.02) after instillation compared to before in brimonidine eyes (p < 0.001 for all). There was a significant miosis continued for at least 6 h (5.95 ± 1.03) in control eyes (p < 0.001). There was no significant change in MRD1, before and after instillation both in brimonidine and control eyes.
CONCLUSIONS:
Brimonidine tartrate 0.15% had a significant miosis under scotopic condition for at least 8 h after instillation and had a significant miosis on the untreated eye for at least 6 h.
AuthorsIbrahim Tuncer, Sinan Bilgin, Mehmet Özgür Zengin, Mehmet Serhat Mangan, Abdullah Karaca, Cezmi Doğan, Esat Çınar
JournalEye (London, England) (Eye (Lond)) Vol. 35 Issue 2 Pg. 672-675 (02 2021) ISSN: 1476-5454 [Electronic] England
PMID32518394 (Publication Type: Controlled Clinical Trial, Journal Article)
Chemical References
  • Ophthalmic Solutions
  • Quinoxalines
  • Brimonidine Tartrate
Topics
  • Adolescent
  • Adult
  • Brimonidine Tartrate
  • Child
  • Eyelids
  • Female
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Pupil
  • Quinoxalines
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: